Evogene director Leon Recanati reports holdings
Evogene Ltd. director Leon Recanati filed a Form 3 reporting his initial ownership in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Evogene Ltd. director Leon Recanati filed a Form 3 reporting his initial ownership in the company. He directly holds 83,886 ordinary shares and multiple stock options over ordinary shares with differing exercise prices and expirations extending through 2035. A footnote explains that the option grant with a 1.29 exercise price vests in four equal quarterly installments from an August 18, 2025 grant date, becoming fully vested after one year.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Ordinary shares | -- | -- | -- |
Footnotes (1)
- F1. The options reported in this row vest equally on a quarterly basis (25% per quarter) such that they will be fully vested on the one-year anniversary of the August 18, 2025 grant date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
